Detalles de la búsqueda
1.
Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
Hepatology
; 2024 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436992
2.
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
J Med Virol
; 96(5): e29675, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38746997
3.
Liver stiffness and spleen stiffness predict distinct liver-related events after hepatitis C eradication with direct-acting antivirals.
J Formos Med Assoc
; 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453531
4.
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis.
J Hepatol
; 78(3): 534-542, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36572349
5.
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol
; 78(2): 281-292, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208843
6.
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study.
Am J Gastroenterol
; 118(11): 1963-1972, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36881437
7.
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
Ann Intern Med
; 175(9): 1221-1229, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35939812
8.
Identification of 13 Novel Loci in a Genome-Wide Association Study on Taiwanese with Hepatocellular Carcinoma.
Int J Mol Sci
; 24(22)2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38003606
9.
Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients.
J Infect Dis
; 225(11): 1974-1981, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894128
10.
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment.
Gut
; 71(1): 176-184, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33408122
11.
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.
Clin Infect Dis
; 75(3): 453-459, 2022 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864948
12.
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial.
Clin Gastroenterol Hepatol
; 20(12): 2800-2808, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864158
13.
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine.
Clin Gastroenterol Hepatol
; 20(4): 874-885.e4, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089852
14.
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR).
Clin Gastroenterol Hepatol
; 20(5): 1151-1162.e6, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34333150
15.
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agents.
J Viral Hepat
; 29(9): 785-794, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657121
16.
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
J Gastroenterol Hepatol
; 37(10): 1901-1910, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790343
17.
Liver and Spleen Stiffness Surveillance Through Elastography During and After Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C.
J Ultrasound Med
; 41(5): 1169-1177, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34415630
18.
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
J Formos Med Assoc
; 121(3): 703-711, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452785
19.
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.
J Formos Med Assoc
; 121(8): 1567-1578, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123849
20.
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
J Infect Dis
; 224(11): 1890-1899, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33999179